モノクローナル抗体治療の世界市場予測2018-2023

【英語タイトル】Global Monoclonal Antibody Therapeutics Market Growth 2018-2023

LP Informationが出版した調査資料(LPIN8N1450)・商品コード:LPIN8N1450
・発行会社(調査会社):LP Information
・発行日:2018年10月22日
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥413,580見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥620,370見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥827,160見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「モノクローナル抗体治療の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、人間、ヒト化、キメラ、その他など、用途別には、病院、診療所、その他などに区分してまとめた調査レポートです。モノクローナル抗体治療のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向、販売チャネルなどの情報が含まれています。
・モノクローナル抗体治療の世界市場概要(サマリー)
・モノクローナル抗体治療の企業別販売量・売上
・モノクローナル抗体治療の企業別市場シェア
・モノクローナル抗体治療の世界市場規模:種類別(人間、ヒト化、キメラ、その他)
・モノクローナル抗体治療の世界市場規模:用途別(病院、診療所、その他)
・モノクローナル抗体治療の米州市場規模(アメリカ、カナダ、メキシコなど)
・モノクローナル抗体治療のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・モノクローナル抗体治療の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・モノクローナル抗体治療の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・モノクローナル抗体治療市場の成長要因・課題・動向
・モノクローナル抗体治療の販売チャネル、流通業者、顧客
・モノクローナル抗体治療の世界市場予測
・モノクローナル抗体治療の米州市場予測(アメリカ、カナダ、メキシコなど)
・モノクローナル抗体治療のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・モノクローナル抗体治療の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・モノクローナル抗体治療の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・モノクローナル抗体治療の世界市場予測:種類別(人間、ヒト化、キメラ、その他)
・モノクローナル抗体治療の世界市場予測:用途別(病院、診療所、その他)
・主要企業分析
【レポートの概要】

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Monoclonal Antibody Therapeutics market for 2018-2023.

For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.
Over the next five years, LPI(LP Information) projects that Monoclonal Antibody Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Human
Humanized
Chimeric
Others
Segmentation by application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Monoclonal Antibody Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Monoclonal Antibody Therapeutics market by identifying its various subsegments.
Focuses on the key global Monoclonal Antibody Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Monoclonal Antibody Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Monoclonal Antibody Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

2018-2023 Global Monoclonal Antibody Therapeutics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Therapeutics Consumption 2013-2023
2.1.2 Monoclonal Antibody Therapeutics Consumption CAGR by Region
2.2 Monoclonal Antibody Therapeutics Segment by Type
2.2.1 Human
2.2.2 Humanized
2.2.3 Chimeric
2.2.4 Others
2.3 Monoclonal Antibody Therapeutics Consumption by Type
2.3.1 Global Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Monoclonal Antibody Therapeutics Sale Price by Type (2013-2018)
2.4 Monoclonal Antibody Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Monoclonal Antibody Therapeutics Consumption by Application
2.5.1 Global Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Monoclonal Antibody Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Monoclonal Antibody Therapeutics Sale Price by Application (2013-2018)

3 Global Monoclonal Antibody Therapeutics by Players
3.1 Global Monoclonal Antibody Therapeutics Sales Market Share by Players
3.1.1 Global Monoclonal Antibody Therapeutics Sales by Players (2016-2018)
3.1.2 Global Monoclonal Antibody Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players
3.2.1 Global Monoclonal Antibody Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Monoclonal Antibody Therapeutics Sale Price by Players
3.4 Global Monoclonal Antibody Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Monoclonal Antibody Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Monoclonal Antibody Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Monoclonal Antibody Therapeutics by Regions
4.1 Monoclonal Antibody Therapeutics by Regions
4.1.1 Global Monoclonal Antibody Therapeutics Consumption by Regions
4.1.2 Global Monoclonal Antibody Therapeutics Value by Regions
4.2 Americas Monoclonal Antibody Therapeutics Consumption Growth
4.3 APAC Monoclonal Antibody Therapeutics Consumption Growth
4.4 Europe Monoclonal Antibody Therapeutics Consumption Growth
4.5 Middle East & Africa Monoclonal Antibody Therapeutics Consumption Growth

5 Americas
5.1 Americas Monoclonal Antibody Therapeutics Consumption by Countries
5.1.1 Americas Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Monoclonal Antibody Therapeutics Value by Countries (2013-2018)
5.2 Americas Monoclonal Antibody Therapeutics Consumption by Type
5.3 Americas Monoclonal Antibody Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Monoclonal Antibody Therapeutics Consumption by Countries
6.1.1 APAC Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Monoclonal Antibody Therapeutics Value by Countries (2013-2018)
6.2 APAC Monoclonal Antibody Therapeutics Consumption by Type
6.3 APAC Monoclonal Antibody Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Monoclonal Antibody Therapeutics by Countries
7.1.1 Europe Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Monoclonal Antibody Therapeutics Value by Countries (2013-2018)
7.2 Europe Monoclonal Antibody Therapeutics Consumption by Type
7.3 Europe Monoclonal Antibody Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Monoclonal Antibody Therapeutics by Countries
8.1.1 Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Monoclonal Antibody Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Type
8.3 Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Monoclonal Antibody Therapeutics Distributors
10.3 Monoclonal Antibody Therapeutics Customer

11 Global Monoclonal Antibody Therapeutics Market Forecast
11.1 Global Monoclonal Antibody Therapeutics Consumption Forecast (2018-2023)
11.2 Global Monoclonal Antibody Therapeutics Forecast by Regions
11.2.1 Global Monoclonal Antibody Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Monoclonal Antibody Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Monoclonal Antibody Therapeutics Forecast by Type
11.8 Global Monoclonal Antibody Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Monoclonal Antibody Therapeutics Product Offered
12.1.3 Pfizer Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Bayer
12.2.1 Company Details
12.2.2 Monoclonal Antibody Therapeutics Product Offered
12.2.3 Bayer Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Monoclonal Antibody Therapeutics Product Offered
12.3.3 Sanofi Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Merck
12.4.1 Company Details
12.4.2 Monoclonal Antibody Therapeutics Product Offered
12.4.3 Merck Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Merck News
12.5 GlaxoSmithKline
12.5.1 Company Details
12.5.2 Monoclonal Antibody Therapeutics Product Offered
12.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline News
12.6 Roche
12.6.1 Company Details
12.6.2 Monoclonal Antibody Therapeutics Product Offered
12.6.3 Roche Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Roche News
12.7 Novartis
12.7.1 Company Details
12.7.2 Monoclonal Antibody Therapeutics Product Offered
12.7.3 Novartis Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Novartis News
12.8 AbbVie
12.8.1 Company Details
12.8.2 Monoclonal Antibody Therapeutics Product Offered
12.8.3 AbbVie Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 AbbVie News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Monoclonal Antibody Therapeutics
Table Product Specifications of Monoclonal Antibody Therapeutics
Figure Monoclonal Antibody Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Monoclonal Antibody Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Monoclonal Antibody Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Monoclonal Antibody Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Human
Table Major Players of Human
Figure Product Picture of Humanized
Table Major Players of Humanized
Figure Product Picture of Chimeric
Table Major Players of Chimeric
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Monoclonal Antibody Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Monoclonal Antibody Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Monoclonal Antibody Therapeutics Value Market Share by Type (2013-2018)
Table Global Monoclonal Antibody Therapeutics Sale Price by Type (2013-2018)
Figure Monoclonal Antibody Therapeutics Consumed in Hospitals
Figure Global Monoclonal Antibody Therapeutics Market: Hospitals (2013-2018) (K Units)
Figure Global Monoclonal Antibody Therapeutics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapeutics Consumed in Clinics
Figure Global Monoclonal Antibody Therapeutics Market: Clinics (2013-2018) (K Units)
Figure Global Monoclonal Antibody Therapeutics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapeutics Consumed in Others
Figure Global Monoclonal Antibody Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Monoclonal Antibody Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Monoclonal Antibody Therapeutics Value by Application (2013-2018)
Table Global Monoclonal Antibody Therapeutics Value Market Share by Application (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Value Market Share by Application (2013-2018)
Table Global Monoclonal Antibody Therapeutics Sale Price by Application (2013-2018)
Table Global Monoclonal Antibody Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Players in 2016
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Players in 2017
Table Global Monoclonal Antibody Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Players in 2016
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Players in 2017
Table Global Monoclonal Antibody Therapeutics Sale Price by Players (2016-2018)
Figure Global Monoclonal Antibody Therapeutics Sale Price by Players in 2017
Table Global Monoclonal Antibody Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Monoclonal Antibody Therapeutics Products Offered
Table Monoclonal Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Monoclonal Antibody Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Monoclonal Antibody Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Monoclonal Antibody Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Monoclonal Antibody Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Monoclonal Antibody Therapeutics Value Market Share by Regions 2013-2018
Figure Global Monoclonal Antibody Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Monoclonal Antibody Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Monoclonal Antibody Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Monoclonal Antibody Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Monoclonal Antibody Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Monoclonal Antibody Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Monoclonal Antibody Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Value 2013-2018 ($ Millions)
Table Americas Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Monoclonal Antibody Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Monoclonal Antibody Therapeutics Consumption Market Share by Countries in 2017
Table Americas Monoclonal Antibody Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Monoclonal Antibody Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Monoclonal Antibody Therapeutics Value Market Share by Countries in 2017
Table Americas Monoclonal Antibody Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Monoclonal Antibody Therapeutics Consumption Market Share by Type in 2017
Table Americas Monoclonal Antibody Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Monoclonal Antibody Therapeutics Consumption Market Share by Application in 2017
Figure United States Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Monoclonal Antibody Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Monoclonal Antibody Therapeutics Consumption Market Share by Countries in 2017
Table APAC Monoclonal Antibody Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Monoclonal Antibody Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Monoclonal Antibody Therapeutics Value Market Share by Countries in 2017
Table APAC Monoclonal Antibody Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Monoclonal Antibody Therapeutics Consumption Market Share by Type in 2017
Table APAC Monoclonal Antibody Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Monoclonal Antibody Therapeutics Consumption Market Share by Application in 2017
Figure China Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Monoclonal Antibody Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Consumption Market Share by Countries in 2017
Table Europe Monoclonal Antibody Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Monoclonal Antibody Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Value Market Share by Countries in 2017
Table Europe Monoclonal Antibody Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Consumption Market Share by Type in 2017
Table Europe Monoclonal Antibody Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Consumption Market Share by Application in 2017
Figure Germany Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Monoclonal Antibody Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Monoclonal Antibody Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Monoclonal Antibody Therapeutics Value Growth 2013-2018 ($ Millions)
Table Monoclonal Antibody Therapeutics Distributors List
Table Monoclonal Antibody Therapeutics Customer List
Figure Global Monoclonal Antibody Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Monoclonal Antibody Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Monoclonal Antibody Therapeutics Consumption Market Forecast by Regions
Table Global Monoclonal Antibody Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapeutics Value Market Share Forecast by Regions
Figure Americas Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure United States Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure United States Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure China Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure China Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure India Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure India Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure France Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure France Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure UK Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure UK Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Monoclonal Antibody Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Monoclonal Antibody Therapeutics Value 2018-2023 ($ Millions)
Table Global Monoclonal Antibody Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Monoclonal Antibody Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Monoclonal Antibody Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Monoclonal Antibody Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Monoclonal Antibody Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Monoclonal Antibody Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Monoclonal Antibody Therapeutics Market Share (2016-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Monoclonal Antibody Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Monoclonal Antibody Therapeutics Market Share (2016-2018)


【レポートのキーワード】

モノクローナル抗体治療、人間、ヒト化、キメラ、病院、診療所

★調査レポート[モノクローナル抗体治療の世界市場予測2018-2023] (コード:LPIN8N1450)販売に関する免責事項を必ずご確認ください。
★調査レポート[モノクローナル抗体治療の世界市場予測2018-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆